Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PREVAIL NY is a New York limited liability company formed in 2020 by JMA to design and manufacture an emergency mechanical ventilation system during the COVID-19 crisis. The organization developed an open-source, low-cost emergency ventilator design intended to augment hospital ventilator capacity when standard FDA-approved ventilators were unavailable. Its system leveraged existing medical equipment such as a bag valve mask and was designed for rapid manufacturability using readily available components. PREVAIL NY appears to have been a special-purpose medical device initiative rather than a traditional biotech or pharmaceutical company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PREVAIL NY.